Skip to main content
PLOS One logoLink to PLOS One
. 2022 Mar 9;17(3):e0263688. doi: 10.1371/journal.pone.0263688

Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in Taiwan

Chih-Ho Hsu 1,2,#, Chen-Lun Chiu 1,#, Yi-Ting Lin 1, Ann-Yu Yu 1, Yen-Te Kang 3, Michael Cherng 3, Yi-Hui Chen 1, Ting-Hui Chuang 4, Hsin-Yi Huang 4, Jwo-Luen Pao 4, Kuo-Hsin Chen 3,5,*, Chih-Hung Chang 4,6,*
Editor: Etsuro Ito7
PMCID: PMC8906606  PMID: 35263347

Abstract

Background

During the COVID-19 surge in Taiwan, the Far East Memorial Hospital established a system including a centralized quarantine unit and triage admission protocol to facilitate acute care surgical inpatient services, prevent nosocomial COVID-19 infection and maintain the efficiency and quality of health care service during the pandemics.

Materials and methods

This retrospective cohort study included patients undergoing acute care surgery. The triage admission protocol was based on rapid antigen tests, Liat® PCR and RT-PCT tests. Type of surgical procedure, patient characteristics, and efficacy indices of the centralized quarantine unit and emergency department (ED) were collected and analyzed before (Phase I: May 11 to July 2, 2021) and after (Phase II: July 3 to July 31, 2021) the system started.

Results

A total of 287 patients (105 in Phase I and 182 in Phase II) were enrolled. Nosocomial COVID-19 infection occur in 27 patients in phase I but zero in phase II. More patients received traumatological, orthopedic, and neurologic surgeries in phase II than in phase I. The patients’ surgical risk classification, median total hospital stay, intensive care unit (ICU) stay, intraoperative blood loss, operation time, and the number of patients requiring postoperative ICU care were similar in both groups. The duration of ED stay and waiting time for acute care surgery were longer in Phase II (397 vs. 532 minutes, p < 0.0001). The duration of ED stay was positively correlated with the number of surgical patients visiting the ED (median = 66 patients, Spearman’s ρ = 0.207) and the occupancy ratio in the centralized quarantine unit on that day (median = 90.63%, Spearman’s ρ = 0.191).

Conclusions

The triage admission protocol provided resilient quarantine needs and sustainable acute care surgical services during the COVID-19 pandemic. The efficiency was related to the number of medical staff dedicated to the centralized quarantine unit and number of surgical patients visited in ED.

Introduction

In late December 2019, the first cases of a novel coronavirus-induced pneumonia were reported in Wuhan, China [1]. The World Health Organization (WHO) officially designated this infectious disease as coronavirus disease 2019 (COVID-19) on February 12, 2020 [2]. Due to the lack of effective medical management in the early period of the outbreak, the COVID-19 pandemic has had an enormous impact worldwide, causing more than 200 million confirmed cases globally and more than 4 million deaths as at August 11, 2021, according to data from the WHO [3, 4].

Taiwan, a country neighboring China, did not develop large-scale local outbreaks at the beginning of the pandemic [5]. Non-pharmaceutical interventions (NPIs), such as widespread lockdowns, quarantines, social distancing, personal hygiene, and the use of facemasks were the main COVID-19 control measures [6]. However, after community transmission of COVID-19 was first reported on May 11, 2021, the disease soon spread into northern Taiwan [7].

During the COVID-19 surge, patients were reluctant to visit hospitals because of the potential for contracting infections in a hospital environment and the government’s “stay at home” policy. However, the acute care surgery demand persisted and constituted most of our medical service during this time. Disease severity and unintended consequences are collateral damage caused by the COVID-19 pandemic. For instance, some studies have investigated the negative influence of the pandemic on the treatment of acute appendicitis, including delays in the time to consultation, longer durations of admission, and higher rates of readmission, complicated appendicitis, and severe peritonitis [8, 9]. Cano-Valderrama et al. also noticed that minor complications in acute care surgery were more common during the pandemic because of significantly delayed arrival at the emergency department and more severe patients undergoing surgery [10].

After a nosocomial COVID-19 outbreak in the Far East Memorial Hospital (FEMH), we reduced ambulatory surgeries, postponed elective surgeries, and deferred hospitalization if possible (Fig 1). Thus, the number of patients undergoing elective and ambulatory operations decreased dramatically in comparison with the previous year; however, the number of patients undergoing acute care surgery remained as stable as before. To address the persistent demand for acute care surgery during the pandemic, we designed a triage admission protocol with a centralized quarantine unit to manage patients after acute care surgery. We hypothesized that this system would significantly prevent another outbreak of nosocomial infections arising from patients and their caregivers after acute care surgery. Furthermore, we hoped that this system might also maintain the efficiency and quality of our health care service during the pandemics and decrease the duration of stay in the emergency department.

Fig 1. Differences in the number of operations performed in the same period (between the 18th and 29th weeks) in 2020 and 2021.

Fig 1

A nosocomial infection occurred in FEMH on May 14, 2021, and policy of reducing surgical services was announced on May 16, 2021 (19th week). Panels A & B, number of operations stratified by department. Panels C & D, number of operations stratified by the nature of surgery (elective, ambulatory, or emergent surgery). GS, general surgery; PEDS, pediatric surgery; CRS, colorectal surgery; NS, neurosurgery; CS, chest surgery; GU, urological procedure; PS, plastic surgery; CVS, cardiovascular surgery; Ortho, orthopedic surgery; OPH, ophthalmological surgery; GYN, gynecological surgery; OS, oral and maxillofacial surgery.

Materials and methods

Study hospital characteristics

New Taipei City is situated in the northern part of Taiwan, and it has the largest population in Taiwan, with approximately 4 million inhabitants. FEMH is the only tertiary medical center in New Taipei City. FEMH is equipped with 1,383 beds and is visited by 6,500 outpatients each day, with approximately 400 patients treated each day in the emergency room, which is ranked fourth nationwide.

The first nosocomial infection was reported in FEMH on May 14, 2021. The nosocomial outbreak resulted in 27 confirmed cases, including 12 patients, 12 caregivers, and three nurses. Two ordinary ward units (total 88 beds) were isolated thereafter. Multidiscipline experts were appointed to the Infection Control and Special Response Committee. The committee addressed nosocomial outbreaks with methods such as increasing the intensive care unit (ICU) capacity, transforming the general ward facilities into dedicated COVID-19 wards, reorganizing physicians and nurses to new tasks, decreasing outpatient services, discouraging ward visits, and shifting to online video or telephone calls. Meanwhile, our hospital was retained as a medical center for severe illness during the surge, treating 11% of the critical COVID-19 patients in Taiwan. As a result, we faced immense pressure in maintaining acute care surgical services during the pandemic, while protecting the medical staff and preventing new nosocomial infections.

Detail of triage admission protocol

As described by Wake et al. [16], the Infection Control and Special Response Committee classified the wards in the FEMH into four zones and set up the entrance criteria of these zones: general wards, green zone; COVID assessment ward, yellow zone; COVID alert, red zone; and COVID, purple zone (see Fig 2). The four-tier triage system was used to stratify surgical patients and their caregivers to proper wards, regardless of whether the patients came from the outpatient department for elective operations or from the emergency department for acute care surgery. The innovation of our protocol is that suspicious or confirmed COVID-19 patients could also be stepped down to less guarded wards after completing isolation. To realize this idea, the Committee transformed a dedicated COVID care unit into a centralized quarantine unit that included yellow and red zones. The Committee also assigned a special medical team in the centralized quarantine unit to demonstrate management of patients after acute care surgery under this triage system. The team included three nurse practitioners and four residents to execute the protocol, and six attending physicians in different surgical subspecialities enrolled as the daily team leader.

Fig 2. Flowchart of the triage admission protocol with a centralized quarantine unit.

Fig 2

RAT, rapid antigen test; FUO, fever of unknown origin.

RT-PCR testing had been indicated as the standard protocol in the diagnosis of COVID-19 [11], but analysis of specimens needed turnaround times of about 3.5 hours in our hospital during the pandemic. To ensure the efficiency and reliability of the triage admission protocol, we incorporated timely and accurate laboratory tests into the system. The tests included the VTrust COVID-19 rapid antigen test (target antigen: SARS-CoV-2 nucleocapsid protein; reaction time: 15 min; positive predictive agreement: 93.1%; negative predictive agreement: 99.6% [12]) and the Cobas® Liat® PCR System (target genome region: RF1a/b and N genes; turnaround time: 20 min; positive predictive agreement: 100%; negative predictive agreement, 97.4% [13]). The Cobas® Liat® PCR System was only indicated for patients from the emergency department who needed acute care surgery. The National Health Insurance Administration of Taiwan funded these tests for inpatients and their caregivers during the pandemic.

Outpatients who were ready to undergo elective operations were first admitted to wards in the green zone. Patients and their caregivers provided nasopharyngeal swab samples for RT-PCR testing 2 days before the scheduled admission date and were admitted only if SARS-CoV-2 was not detected by RT-PCR. The patients subsequently received surgical services depending on their clinical needs. The Committee monitored occult COVID-19 infection in the hospital by performing rapid antigen tests on patients and their caregivers every 7 days.

Patients who underwent non-deferrable surgery due to acute disease (such as laparoscopic appendectomy for ruptured appendicitis, orthopedic fixation surgery for displaced fractures, herniorrhaphy for incarcerated hernia) were admitted to wards in the yellow zone. The patients underwent Liat® PCR testing at the outdoor COVID triage center in ED once consultants decided to arrange for a non-deferrable operation, and they were allowed to undergo surgery in an ordinary operation room if the Liat® PCR results were negative. The patient’s caregiver was allowed entry into the hospital only after showing negative results in a rapid antigen test and was required to complete an RT-PCR test within 24 hours after entering the yellow zone. When patients and their family caregivers tested negative for SARS-CoV-2, the primary care medical team continued their treatment in the yellow zone ward or transferred them to the green zone ward if their admission was estimated to last longer than a week. We also discouraged changes in caregivers for patients who were in the green or yellow zones. If there was a change, the new family caregiver was required to undergo a self-paid RT-PCR examination (approximately 190 USD) to prove SARS-CoV-2 negativity.

The Committee prepared six COVID alert wards (red zone) for surgical patients who showed negative RT-PCR or Liat® PCR test results and met any of the following criteria:

  • Patients who developed nosocomial pneumonia and were recommended quarantine by the Infection Control Committee

  • Patients who developed fever of unknown origin (FUO) and were recommended quarantine by the Infection Control Committee

  • Patients requiring perioperative care who showed positive results in the rapid antigen test and negative results in the RT-PCR test

  • Patients who had been in close contact with COVID-confirmed people within the last two weeks

  • Patients who were exposed to a cluster of COVID-19 infections among their co-residents

  • Patients who needed perioperative care during their home isolation period

  • Patients exposed to any specific COVID-19 outbreak area in the last two weeks

Patients admitted to the red zone due to contact history were quarantined in the red zone for 14 days to monitor symptoms of COVID-19 infection. RT-PCR testing was performed if the patient became symptomatic. For patients admitted to the red zone because of suspected pneumonia, FUO, or discrepancy between the results of the rapid antigen test and RT-PCR test, the Committee recommended follow-up evaluations with at least one nasopharyngeal swab RT-PCR test at intervals of 48 hours. According to Lauer et al. [14], the incubation period of SARS-CoV-2 is estimated to be 3 to 7 days, with a range of 2 to 14 days, so the Committee decided to remove patients from quarantine gradually. Thus, patients in the red zone who completed the quarantine and remained RT-PCR-negative were stepped down to the yellow zone, monitored for 3 days, and then discharged or transferred to the green zone according to their clinical needs.

All RT-PCR-positive patients were placed in the COVID-confirmed ward (purple zone) where the patients were under the care of dedicated nurses and internists who specialized in infectious diseases and chest medicine. These patients were released from isolation when they met all of the following criteria announced by Taiwan CDC: (1) the patient is afebrile for at least 24 hours and symptoms subside or show improvement on chest radiographs, (2) at least 10 days have passed after the initial symptom onset or first positive RT-PCR result if the patient was initially asymptomatic, (3) one set of specimens from the respiratory tract (sputum, oropharyngeal, or nasopharyngeal swabs) showed negative results for SARS-CoV-2 or a Ct value > 30 in RT-PCR. Using the same principle of gradually removing patients from quarantine, patients from the purple zone were stepped down to the red zone, monitored for 3 days, further stepped down to the yellow zone, monitored for 3 days, and then discharged or transferred to the green zone according to clinical needs.

Critical surgical patients were transferred to ordinary ICU (green zone) or dedicated ICU (purple zone), depending on whether they were diagnosed with COVID-19 or not. We encouraged surgeons to communicate with intensivists by phone, and the intensivists in ICU were primarily responsible for managing patients’ conditions.

To facilitate execution of the centralized quarantine unit and triage system, the special medical team also educated staff, patients, and caregivers on the ideal approaches to prepare themselves in the hospital. For example, the Committee strongly recommended that all medical staff wear basic personal protective equipment (PPE) in the green and yellow zones. If working in the red and purple zones or performing any aerosol-generating procedures, medical staff were required to upgrade to advanced PPE (see Fig 3). A special medical team in the centralized quarantine unit helped complete RT-PCR tests for family caregivers within 24 hours and treat patients in COVID alert wards. The team communicated with the surgeons whose patients were admitted in the yellow zone about the timing of discharge or transfer to the green zone. They also monitored febrile surgical patients in the green zone to identify those who might need to be transferred to the red zone if they were highly suspicious of COVID-19 infection. When patients were scheduled to undergo emergent operations, medical staff used shared decision-making tools to allow them to understand the benefits and risks of admission during the COVID-19 pandemics. We also provided posters and videos online (https://www.youtube.com/watch?v=EGkBic_r2ek) to educate patients and caregivers to maintain appropriate levels of hygiene during admission. All of these efforts were made to facilitate application of this triage system and decrease nosocomial COVID-19 transmission.

Fig 3. Recommendation of personal protective equipment for medical staff in different admission areas.

Fig 3

Data collection

From May 11 to July 31, 2021, patients who underwent acute care surgery after evaluation in the emergency department (ED) were included in this study. We defined phase I as the period before the centralized quarantine unit was established (from May 11 to July 2), and phase II as the period after the centralized quarantine unit was established (from July 3 to July 31). A wide variety of acute care surgeries were included, as follows: general surgery, neurosurgery, plastic surgery, thoracic surgery, genitourinary surgery, colorectal surgery, orthopedic surgery, traumatological surgery, pediatric surgery, otorhinolaryngologic surgery, ophthalmologic surgery, and gynecologic surgery. Patient demographic data, such as age, sex, operation codes, operation time, blood loss, demand for postoperative ICU care, and postoperative complications were documented. The American Society Anesthesiologists (ASA) physical status classification system was used as a simple categorization of a patient’s status to help predict and record operative risk [15]. We also evaluated the indices related to administration efficacy, including time spent in the ED, number of surgical patients visiting the ED per day, number of patients admitted to and discharged from centralized quarantine units per day, length of general ward stay, length of ICU stay, length of total hospital stay, and occupancy and discharge ratios in the centralized quarantine units. The ED stay time was calculated from the time when the patient was registered in the ED to the time when the patient was transferred to the operating room or ward.

Ethical statement

The study was ethically approved by the Institutional Review Board of FEMH (Reference FEMH No.: 110181-E.) Permission was sought from the hospital administration before data collection and analysis. Patient records and information was anonymized prior to analysis to ensure confidentiality of individual patient information. The ethics committee waived the requirement for individual patient consent due to the retrospective nature of the study.

Statistics

Data were summarized as the median, interquartile range (IQR), and total range for continuous variables and as proportions for categorical variables. The Kolmogorov–Smirnov goodness-of-fit test and normality plot were used to measure the distributional characteristics of the study variables. Since the target variables were not normally distributed, non-parametric statistical analysis was used to verify the proposed relationships. Thus, the Mann-Whitney U (Wilcoxon Rank Sum) test was used to compare the significant outcomes between the two independent groups. Spearman’s rank correlation analysis was used to determine the correlation between continuous variables. All analyses were performed using SPSS Statistics for Windows (Version 22.0, IBM Corp, Armonk, NY, USA), and differences were considered statistically significant at p < 0.05.

Results

A total of 287 patients received acute care surgery after evaluation at the ED of FEMH between May 11 and July 31, 2021 (Table 1). One hundred and five patients (36.6%) were admitted to the green zone in phase I, and 182 patients (63.4%) were admitted to the yellow zone in phase II. Twenty-seven cases of nosocomial COVID-19 developed in phase I but zero from patients or caregivers in the centralized quarantine unit, and three patients were transferred to the red zone (one from the green zone, and two from the yellow zone) due to the rapid onset of fever of unknown origin. All red zone patients were confirmed to be SARS-CoV-2 PCR-negative at least three times. Among the 182 patients who were admitted in yellow zone, 150 patients (82.4%) were discharged to home, 18 patients (9.9%) were transferred to green zone for prolonged medical needs, 12 patients (6.6%) were transferred to ICU postoperatively and two patients (1.1%) died due to severe surgical complications.

Table 1. Basic characteristics of the patients.

Factors Phase I Phase II Total P-value*
(n = 105) (n = 182) (n = 287)
Age (years)
Median (range) 51 (17–87) 56 (17–89) 54 (17–89) 0.149
Sex 0.003
 Male 72 93 165 (57.5%)
 Female 33 89 122 (36.2%)
Surgery departments 0.518
 General surgery 53 51 104 (36.2%)
 Neurosurgery 3 8 11 (3.8%)
 Plastic surgery 5 3 8 (2.8%)
 Thoracic surgery 6 3 9 (3.1%)
 Genitourinary surgery 9 10 19 (6.6%)
 Colorectal surgery 2 0 2 (0.7%)
 Orthopedic surgery 17 88 105 (36.7%)
 Traumatological surgery 1 6 7 (2.4%)
 Pediatric surgery 0 1 1 (0.3%)
 Otorhinolaryngologic surgery 4 3 7 (2.4%)
 Ophthalmologic surgery 3 3 6 (2.1%)
 Gynecologic surgery 2 6 8 (2.8%)
ASA classification [15] 0.095
 ASA I 6 12 18
 ASA II 66 126 192
 ASA III 28 36 64
 ASA IV 2 1 3
Operation time (mins)
 Median (Q1-Q3) 60 (50–100) 85 (60–120) 70 0.1
Estimated blood loss (ml)
 Median (Q1-Q3) 10 (5–50) 10 (5–50) 10 0.426
Postoperative ICU care 6 15 21 0.424
Length of ICU stay (days)
 Median (Q1-Q3) 3 (3–8) 3 (2–4) 3 0.461
Length of total hospital stay (days)
 Median (Q1-Q3) 4 (3–8) 4 (3–7) 4 0.736
Length of general ward stay (days)
 Median (Q1-Q3) 4 (3–8) 4 (3–6) 4 0.619

ASA classification, The American Society Anesthesiologists (ASA) physical status classification system; ICU, intensive care unit.

* Results of the Mann-Whitney U test.

Among the 287 patients, orthopedic surgery was the most frequent acute care surgery during this period (n = 105, 36.7%), followed by general surgery (n = 104, 36.2%). The proportions of patients receiving traumatological, orthopedic, and neurologic surgeries increased significantly (500%, 418%, and 167%) from phase I to phase II. Most patients were classified as ASA II (n = 192, 66.9%). The unit operated efficiently, which was evidenced by the large number of patients admitted to and discharged from it (median, 16.5; IQR = 11,7), the high occupancy ratio (median, 90.63%; IQR = 12.5%), and the high discharge ratio (28.13%, IQR = 18.75%) (Table 2).

Table 2. Efficacy index of ED and the centralized quarantine unit.

Factors Phase I Phase II Total P-value* Spearman’s ρ
(n = 105) (n = 182) (n = 287)
Length of ED stay (mins) 397 (285–570) 532 (340–1153) 465 (318–872.5) <0.0001 1
Number of surgical patients visiting in ED per day 40 (32–51) 66 (61–74) 59 (47–72) <0.0001 0.207§
Number of patients utilizing centralized quarantine unit per day N/A 16.5 (9–20.7)
Occupying ratio in centralized quarantine unit per day (%) N/A 90.63 (84.38–96.88) 0.191§
Discharging ratio in centralized quarantine unit per day (%) N/A 28.13 (15.63–34.38) -0.003

ED, emergency department.

*Result of Mann-Whitney U test.

§P-value < 0.05 in Spearman’s rank correlation analysis.

A comparison of the findings obtained in phase I and phase II showed no differences in the operation time (p = 0.1), blood loss (p = 0.426), length of total hospital stay (p = 0.736), and length of general ward stay (p = 0.619). Six patients needed intensive care after the operation in phase I and 15 patients required it in phase II. The length of ICU stay did not differ between the two phases (p = 0.461).

In phase II, the time of patient stay in the ED was significantly longer (397 vs. 532 min, p < 0.001) than that in phase I (Table 2). The number of surgical patients visiting the ED per day in phase II was also significantly higher (40 vs. 66, p < 0.001) than that in phase I. The longer staying time in the ED was positively correlated with the number of surgical patients visiting the ED (Spearman’s ρ coefficient = 0.207) and the occupancy ratio in the centralized quarantine unit on that day (Spearman’s ρ coefficient = 0.191).

Discussion

The triage admission protocol and centralized quarantine unit ensured that the hospital was protected from a new outbreak of nosocomial COVID infections. It also allowed the hospital to increase the volume of inpatient services for patients undergoing non-deferrable traumatological, orthopedic, and neurologic surgeries. The quality of surgical service was considered to be stable because the operation time, intraoperative blood loss, length of hospital stay, and ICU stay were not statistically different between the two periods. Although the duration of ED stay, which serves as an index of administrative efficiency, could not be reduced by this system, this factor was more related to the increasing demand for ED visits and inpatient services.

The reported experiences in hospitals in the UK and South Korea have highlighted the spread of nosocomial COVID-19 infections among medical workers and patients [1618]. Some useful strategies that were applied in FEMH to address this problem are listed as follows: (1) regular SARS-CoV-2 PCR testing for medical workers in high-risk facilities, (2) isolation of diagnosed COVID-19 cases until they showed two negative samples (including nasopharyngeal swab, throat swab, or deep respiratory sputum on the same day) with complete resolution of symptoms, (3) social distancing (1.5-meter rule in non-clinical areas) in staff areas and virtual meetings in the hospital; (4) use of proper PPE by medical staff in clinical practice; (5) administration of approved COVID-19 vaccines to all hospital staff and associated cooperation partners; and (6) availability of highly efficient and accurate SARS-CoV-2 PCR testing throughout the day. Caregivers, however, are another potential source of viral shedding because they move between community and healthcare facilities in pandemics. In Brazil, Passarelli et al. surveyed 150 asymptomatic visitors using RT-PCR with nasopharyngeal specimens in a single day, and six of the 150 (4%) asymptomatic visitors were diagnosed with COVID-19 at a hospital with a universal masking policy [19]. Two inpatients (contacts) subsequently developed symptoms.

In Taiwan, several healthcare facilities have reported nosocomial infections since May 2021, including a total of 137 medical staff, 104 patients, and 49 caregivers (Table 3). Caregivers form the medium for viral shedding between hospitals and communities. These experiences and evidence confirm that caregiver management is a key factor in preventing hospital transmission in the future.

Table 3. Number of COVID-19 nosocomial infections (n = 290).

Type of personnel
 Patients 104
 Caregivers 49
 Health care workers
  Health care assistants 83
  Nurses 43
  Physicians 11
Type of health care institute
 Medical center 63
 Regional hospital 218
 District hospital 3
 Clinic 6

Summary of nosocomial COVID-19 infections in Taiwan between January 2020 and August 2021. Data are adapted from a webinar by Da-Cheng Qu, Taipei Municipal Hospital, 2021. https://www.youtube.com/watch?v=tOgEPFoUnjY. Permission for citation was obtained from the author.

Some COVID-19 admission triage systems have been reported and applied in the context of different clinical needs and hospital capacities. Wake et al. implemented a clinical assessment tool based on rapid SARS-CoV-2 PCR testing, clinical history and findings, laboratory results, and radiologic results to improve the effectiveness of COVID-19 triage and admission. They categorized patients into four tiers—COVID 0 (negative/not suspected), COVID 1 (unlikely/low risk), COVID 2 (likely/high risk), and COVID 3 (positive)—and allocated these patients to the non-COVID ward, assessment ward, and COVID ward. Patients in the non-COVID ward were assessed for their daily COVID risk level, and they were upgraded to COVID 1/2/3 if the risk level increased [16]. Deora et al. proposed a flowchart to manage neurosurgical patients [20]. In our study, patients from the outpatient service had to undergo RT-PCR before admission for elective surgery, and they were admitted to the green zone ward perioperatively only if their RT-PCR test was negative. However, if the patients presented to the ED, they would receive a screening questionnaire, chest computed tomography, and rapid antigen test first as triage. Emergency surgery was indicated if the patient had non-deferable disease, and the rapid antigen test results classified patients into the red zone (rapid antigen test positive) or orange zone (rapid antigen test negative). The patients would subsequently undergo operation and postoperative care in dedicated units in the red and orange zones, respectively. On the other hand, patients who required elective or semi-emergent surgery would complete an RT-PCR test first and were admitted to the green zone if the RT-PCR test showed negative results. Donà et al. reported their pathways in the ED of a pediatric hospital to stratify children and their caregivers according to clinical characteristics, concomitant comorbidities, and epidemiological risk of COVID-19 [21]. To prevent in-hospital virus spread from asymptomatic children or caregivers, the authors suggested nasopharyngeal swab testing for both children and caregivers if hospitalization was needed. Our triage protocol used the strengths of these forementioned systems. The four-tier triage protocol was based on clinical condition, rapid COVID-19 antigen test, Liat® PCR System and RT-PCR testing. It could be applied in both elective and acute surgical patients according to clinical urgency. Inpatient’s family caregivers were also evaluated in the protocol by rapid COVID-19 antigen tests and RT-PCR testing. The protocol also allowed patients to be upgraded or downgraded in different tiers, so that the medical resources could be utilized accordingly. Therefore, we considered that this novel triage admission protocol made our hospital sustainable and resilient in the COVID-19 pandemic, but extra laboratory exams would also increase prolonged ED stay when surgical patients from ED gradually increased [22].

At the beginning of the COVID-19 pandemic, all healthcare workers were reorganized and reassigned to new hospital tasks. For example, frontline ward nurses were assigned to dedicated COVID-19 wards, COVID rapid screening stations, and vaccine administration stations in communities, and specialized quarantine facilities outside the hospital. When nurses had different work contents, some discouraging factors such as detailed policies for infection control, long-term PPE discomfort, and frustration were negatively associated with nurses’ work engagement [23]. In addition, since we planned to increase inpatient services for patients after acute care surgeries, nurses could not leave and return to their original working environment because of the persistence of the COVID-19 pandemic. Therefore, appropriate workload planning for the limited number of nurses who were available for inpatient services was an important part of planning for our centralized quarantine unit. For instance, to address the demand arising from a gradual increase in the number of surgical patients in the ED, we expanded the yellow zone from 20 to 32 beds after recruiting nurses from 5 to 10 people per day. Despite controlling the admission days and transferring patients to the green zone if they needed longer inpatient treatment, the occupancy ratio in the yellow zone remained high. The large number of patients entering and leaving the unit substantially increased the doctors’ and nurses’ workloads.

This study had some limitations. First, this triage admission protocol with a centralized quarantine unit was applied to a single well-organized private tertiary medical center in Taiwan. Administrative policies, hospital culture, and healthcare insurance payers may differ across healthcare facilities and countries; thus, the efficacy of this system may not be reproducible in other facilities. Second, the COVID-19 pandemic in Taiwan was rapidly controlled by multiple approaches. For example, the Central Epidemic Command Center (CECC) in Taiwan restricted NPIs and instead encouraged wide screening in specific communities to identify asymptomatic COVID-19 patients. Some medical centers, including FEMH, treated moderate and severe COVID-19 patients inside hospitals and also set up special quarantine facilities outside the hospitals to manage most mild symptomatic COVID-19 patients, thereby preserving healthcare capacity for other severe diseases. Most importantly, the CECC encouraged vaccination in the population of Taiwan with the help of other countries, including Japan, the United States, Lithuania, Slovakia, the Czech Republic, and Poland. The peak of this pandemic was reached on May 28, with 597 confirmed cases, and only 17 confirmed cases were reported on July 31 [24]. Thus, the absence of nosocomial infection in this study might be related to the low prevalence of COVID-19 in Taiwan during this time.

Conclusion

In summary, we utilized a rapid antigen test, Liat® PCR, and RT-PCR tests as the basis for designing a triage admission protocol to manage patients from EDs who needed acute care surgery. Zero nosocomial infection occurred when we applied this triage admission protocol. The centralized quarantine unit addressed the quarantine requirements for both patients and family caregivers. The efficiency of the unit is related to the number of medical staff dedicated and number of surgical patients visited in ED. Overall, this system provided resilient quarantine needs and sustainable acute care surgical services in our hospital during the COVID-19 pandemic.

Supporting information

S1 Data

(XLSX)

Acknowledgments

We are grateful to all the staff members who assisted in this study.

Data Availability

The data underlying the results presented in the study are provided in the supplemental information.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New Engl J Med. 2020;382: 1199–1207. doi: 10.1056/NEJMoa2001316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Liu Y-C, Kuo R-L, Shih S-R. COVID-19: The first documented coronavirus pandemic in history. Biomed J. 2020;43: 328–333. doi: 10.1016/j.bj.2020.04.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kim PS, Read SW, Fauci AS. Therapy for Early COVID-19. Jama. 2020;324: 2149–2150. doi: 10.1001/jama.2020.22813 [DOI] [PubMed] [Google Scholar]
  • 4.WHO COVID-19 Dashboard. [cited 1 Sep 2021]. https://covid19.who.int/
  • 5.Chen S-C. Taiwan’s experience in fighting COVID-19. Nat Immunol. 2021;22: 393–394. doi: 10.1038/s41590-021-00908-2 [DOI] [PubMed] [Google Scholar]
  • 6.Cheng H-Y, Huang AS-E. Proactive and blended approach for COVID-19 control in Taiwan. Biochem Bioph Res Co. 2020;538: 238–243. doi: 10.1016/j.bbrc.2020.10.100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Taiwan Centers for Disease Control. Press releases: CECC confirms 7 more indigenous cases; one contact of Case #1187 found to have COVID-19 and six cases under investigation. 2021; 5:11. Available from: https://www.cdc.gov.tw/En/Category/ListContent/tov1jahKUv8RGSbvmzLwFg?uaid=AjK-JHPHnPq01NQueiQyPA [Google Scholar]
  • 8.Dreifuss NH, Schlottmann F, Sadava EE, Rotholtz NA. Acute appendicitis does not quarantine: surgical outcomes of laparoscopic appendectomy in COVID-19 times. Brit J Surg. 2020;107: e368–e369. doi: 10.1002/bjs.11806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Finkelstein P, Picado O, Muddasani K, Wodnicki H, Mesko T, Unger S, et al. A Retrospective Analysis of the Trends in Acute Appendicitis During the COVID-19 Pandemic. J Laparoendosc Adv S. 2021;31: 243–246. doi: 10.1089/lap.2020.0749 [DOI] [PubMed] [Google Scholar]
  • 10.Cano-Valderrama O, Morales X, Ferrigni CJ, Martín-Antona E, Turrado V, García A, et al. Acute Care Surgery during the COVID-19 pandemic in Spain: Changes in volume, causes and complications. A multicentre retrospective cohort study. Int J Surg. 2020;80: 157–161. doi: 10.1016/j.ijsu.2020.07.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Burke SA. CDC 2019 Novel Coronavirus (nCoV) Real-Time RT-PCR Diagnostic Panel—Instructions for Use. 2021. https://www.fda.gov/media/134922/download [DOI] [PMC free article] [PubMed]
  • 12.Corp. TT. User manual of VTrust COVID-19 Antigen Rapid Test. 2021. https://taidoc.com/wp-content/uploads/2021/04/TD-4531-DM_for-professional-use.pdf
  • 13.Hansen G, Marino J, Wang Z-X, Beavis KG, Rodrigo J, Labog K, et al. Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study. J Clin Microbiol. 2021;59. doi: 10.1128/JCM.02811-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172: 577–582. doi: 10.7326/M20-0504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Horvath B, Kloesel B, Todd MM, Cole DJ, Prielipp RC. The Evolution, Current Value, and Future of the American Society of Anesthesiologists Physical Status Classification System. Anesthesiology. 2021;135: 904–919. doi: 10.1097/ALN.0000000000003947 [DOI] [PubMed] [Google Scholar]
  • 16.Wake RM, Morgan M, Choi J, Winn S. Reducing nosocomial transmission of COVID-19: implementation of a COVID-19 triage system. Clin Med. 2020;20: clinmed.2020-0411. doi: 10.7861/clinmed.2020-0411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kim J-H, An JA-R, Min P, Bitton A, Gawande AA. How South Korea Responded to the Covid-19 Outbreak in Daegu. Nejm Catal. 2020;1. doi: 10.1056/cat.20.0159 [DOI] [Google Scholar]
  • 18.Jewkes SV, Zhang Y, Nicholl DJ. Nosocomial spread of COVID-19: lessons learned from an audit on a stroke/neurology ward in a UK district general hospital. Clin Med. 2020;20: clinmed.2020-0422. doi: 10.7861/clinmed.2020-0422 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Passarelli VC, Faico-Filho K, Moreira LVL, Cunha AP, Carvalho JMA, Barbosa GR, et al. Asymptomatic COVID-19 in hospital visitors: underestimated potential of viral shedding. Int J Infect Dis. 2020;102: 412–414. doi: 10.1016/j.ijid.2020.10.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Deora H, Dange P, Patel K, Shashidhar A, Tyagi G, Pruthi N, et al. Management of Neurosurgical Cases in a Tertiary Care Referral Hospital During the COVID-19 Pandemic: Lessons from a Middle-Income Country. World Neurosurg. 2021;148: e197–e208. doi: 10.1016/j.wneu.2020.12.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Donà D, Masiero S, Costenaro P, Premuda MT, Rossin S, Perilongo G, et al. Children’s Hospital Management in the COVID-19 Era: The Reorganization of a Tertiary Care Pediatric Emergency Department in Northern Italy. Frontiers Pediatrics. 2020;8: 594831. doi: 10.3389/fped.2020.594831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Krutsri C, Singhatas P, Sumpritpradit P, Thampongsa T, Phuwapraisirisan S, Gesprasert G, et al. Impact of the COVID-19 pandemic on the outcome, morbidity, and mortality of acute care surgery patients: A retrospective cohort study. Int J Surg Open. 2021;28: 50–55. doi: 10.1016/j.ijso.2020.11.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zhang M, zhang P, Liu Y, Wang H, Hu K, Du M. Influence of perceived stress and workload on work engagement in front-line nurses during COVID-19 pandemic. J Clin Nurs. 2021;30: 1584–1595. doi: 10.1111/jocn.15707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Our World in Data. [cited 1 Sep 2021]. https://ourworldindata.org/coronavirus

Decision Letter 0

Etsuro Ito

3 Dec 2021

PONE-D-21-34174Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in TaiwanPLOS ONE

Dear Dr. Chen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please re-organize your manuscript to let the reviewers and the general readers easily read it.

Please submit your revised manuscript by Jan 17 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Etsuro Ito

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4. Your abstract cannot contain citations. Please only include citations in the body text of the manuscript, and ensure that they remain in ascending numerical order on first mention.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study addressedopne method of triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic in one medical center. I have somes suggestions listed below.

1. Please correct the mistake of including English-edition highlights.

2. Taiwan demonstrated the effective control of COVID-19 pandemic. From the experiences in one Taiwan medical center, other countried may learn something from Taiwan. Although this study illustrated one policy of allocation of the patients in need of acute care surgery, the clinical benefit is lacking. In addition to the number of nosocomial infection, I wonder if this novel triage contributes to the less burden of medical professionals or reduction of medical costs.

Further, what is your SOP for the surgical patients with confirmed COVID-19?

Reviewer #2: This article described the comprehensive practice handling acute surgery and pre and post OP care during COVID-19 outbreak in the FEMH. The experience was very precious and deserved recording. However, there are many parts that need to be clarified, as followed in detailed:

Major concerns:

1. First of all, the manuscript was not well-organized. It made the reviewer uncomfortable very much to review it.

2. The major drawback is no COVID-19 confirmed cases admitted to the unit during the study period. Thus, the study goal, to prevent nosocomial COVID-19 infection was not possible to achieve, despite the authors described in details about the implementation of triage admission protocol and centralized quarantine.

3. It’s suggested to describe the scale, involvement and duration of nosocomial outbreak in FEMH. Did the outbreak continue during the study periods?

4. The mean waiting time in ED was longer in phase 1 than phase 2 (397 vs. 532 minutes, p < 0.0001). Although the authors explained that’s positively correlated with the number of surgical patients visiting, it’s suggested to explain more for the triage admission policy. Moreover, there was two different screening methods employed, i.e., RT-PCR, and rapid Ag test + Liat PCR test, respectively. Above 2 methods could have different turn around time. Furthermore, the mean numbers of staff members could be different in these 2 periods, too. The authors may try to put more variables in to analysis.

5. In the table 1, the authors described mean ICU stay was 3 days in both groups Please clarify the zone color of ICU in FEMH according to the triage admission policy. Did the medical teams continue the ICU care? What is the level of PPE ICU?

6. The authors did not analyze the needed staff numbers for implementing triage admission and centralized quarantine.

7. The authors mentioned that hired foreign caregivers management is a key factor in preventing hospital transmission. Above view point was not relevant to the study results.

Other suggestions:

1. In Background part of Abstract, line 27-31. Suggest briefly describe why need to establish the system? For example: no space for surgery during pandemic period? Or patients receiving surgery had higher risk of COVID19 infection than before?

2. In Material and Method part of Abstract, line 33-39. Suggest briefly describe the composition of this system.

3. In Result part of Abstract, line 46-47. “The duration of ED stay and waiting time for acute care surgery were longer in Phase II (397 vs. 532 minutes, p < 0.0001)”: Does it mean the duration of ED stay and waiting time were worsen after the system? Suggest show the advantage of this system in the Result part of Abstract.

4. In Conclusion part of Abstract, line 52-57. Suggest briefly describe the advantage of this system.

5. In Introduction part, line 72-79. “after community transmission of COVID-19…online video or telephone calls.”. Is this part so-called “Triage admission protocol with a centralized quarantine unit”? If YES, these sentences should be put in the Result part. If NO, suggest delete these sentences since they had no correlation with the title.

6. In Introduction part, line 80-94. Suggest revise these sentences to focus on the frequent delay of surgery during pandemic period and the drawback of delay of surgery.

7. In Introduction part, line 100-104, Is there any reference for this system?

8. In Method part, line 132-134, the wards were classified into four parts, is there any reference for this classification? And who decided how to classify these wards?

9. In Method part, line 139, about the COVID care unit, please describe the member of this unit.

10. In Method part, line 140, about the medical team, please describe the member of this team.

11. In Method part, line 147-148. What is the relationship between “reliability of the triage system” with “timely and accurate laboratory tests”?

12. In Method part, line 156-236 “Outpatients who were….. decrease nosocomial COVID-19 transmission..” The authors should describe which part is the regulation of the Taiwan government? Which part consult the reference? And which part is the novel innovation of the hospital?

13. In Table 1. Suggest to provide P-value for Age, Gender, Surgery department, and ASA classification.

14. There should be reference and brief description of ASA classification in Method part and Table 1.

15. In Result part, line 301-331. The authors should try to show the advantage of this “triage admission protocol”. Is there any part of Phase II better than Phase I ?

16. In Discussion part, line 335-338. “The triage admission protocol……and neurologic surgeries.” Are these conclusions proper according to the result of this study? For example, how to prove “The triage admission protocol and centralized quarantine unit secured the hospital”?

17. In Discussion part, line 363-366 “Caregivers form the…. hospitals.” Please cite the reference.

18. Table 3, Line 375, “Data are adapted from a webinar by Da-Cheng Qu, Taipei Municipal” Is there any copy-right issue?

19. Is Discussion part, line 378-405. Please compare the advantage and disadvantage between these references and the result of this study.

20. In Discussion part, line 406-444. Is there any correlation between these discussions with the result of this study? If No, may consider delete these sentences.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Mar 9;17(3):e0263688. doi: 10.1371/journal.pone.0263688.r002

Author response to Decision Letter 0


1 Jan 2022

Dear reviewer:

We are appreciated for your recommendation for the manuscript. All of your concern are replied in the file "Response to reviewers," and the manuscript is revised according to your precious comment.

Best regards,

Dr. ChihHo Hsu and Dr. KuoHsin Chen

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Etsuro Ito

17 Jan 2022

PONE-D-21-34174R1Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in TaiwanPLOS ONE

Dear Dr. Chen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Etsuro Ito

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: Thanks for the dedicated reply from the authors of the article ” Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in Taiwan”

Still, there are some suggestions the authors need to further address and revise in this manuscript, as followed:

1. The authors described the disadvantages of the longer duration of ED stay and waiting time for acute care surgery in Phase II, and correlated the phenomenon to the number of surgical patients visiting the ED and the occupancy ratio in the centralized quarantine unit in the Results. However, no further discussion about the true cause of long ED stay was addressed in the Discussions. Finally in the Conclusions, the authors stated the efficiency was related to the number of medical staff dedicated to the centralized quarantine unit. Please revise and make a logical statement according to the points we emphasize above.

2. Please provide more data regarding the occupancy of purple zone in centralized quarantine unit during phase II period.

3. In the abstract, it is suggested that:

(1) Add more in the background about ” Why need the centralized quarantine unit and triage admission protocol?” (line 28-31)

(2) Provide the correct number of “nosocomial COVID-19 infection” in phase I and II. (line 42-50)

(3) Provide more statements about the infection control or clinical significance of the centralized quarantine unit and triage admission protocol, especially which outcome is better after intervention (phase II compared to phase I).

4. In Line 71-73 “However, after community transmission of……into northern Taiwan.” Please cite the reference.

5. In the Method part, it is suggested to highlight what is the novel innovation of the protocol in this study?

6. In Line 311-318 “Case 1……. and suspicious pneumonia.” Please clarify what is the significance of these three patients?

7. In the Result part, please state more clearly about which outcome are better in phase II than phase I.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Etsuro Ito

25 Jan 2022

Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in Taiwan

PONE-D-21-34174R2

Dear Dr. Chen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Etsuro Ito

Academic Editor

PLOS ONE

Acceptance letter

Etsuro Ito

27 Jan 2022

PONE-D-21-34174R2

Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in Taiwan

Dear Dr. Chen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Etsuro Ito

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The data underlying the results presented in the study are provided in the supplemental information.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES